SCHEMBL24328560

SCHEMBL24328560

CN1CCN(c2ccc(N)c3c2CC(C)(C)C3)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KDM4E B2RXH2 4/20 0.50
MAPT P10636 3/20 0.50
ADRA2C P18825 3/20 0.50
GAA P10253 2/20 0.50
PTK2B Q14289 2/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
POLB P06746 1/20 0.49
RAD52 P43351 1/20 0.45
HSD17B10 Q99714 1/20 0.44
GFER P55789 1/20 0.41
KMT2A Q03164 1/20 0.41
ESR2 Q92731 1/20 0.41
NCF1 P14598 2/20 0.37
DRD2 P14416 3/20 0.37
DRD3 P35462 3/20 0.37
DRD1 P21728 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24328518 0.86 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL7426055 0.78 KDM4E (0.51) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL24327497 0.77 GAA (0.36) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL24328562 0.75 KDM4E (0.49) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL29661478 0.75 KDM4E (0.49) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL972216 0.74 ADRA2C (0.55) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL2894409 0.72 ALDH1A1 (0.60) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL16514423 0.70 ALDH1A1 (0.62) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL18861760 0.69 ALDH1A1 (0.75) ALDH1A1L3MBTL1KDM4EMAPTADRA2C
SCHEMBL3623865 0.69 ADRA2C (0.62) ALDH1A1L3MBTL1KDM4EMAPTADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed